Skip to Main Content

IMCS

  • sam patrick posted an article
    Student find recruiters "ready and waiting" to interview themfor life sciences jobs see more

    In recognition of the importance of adding talented workers for the booming life sciences industry in South Carolina, Midlands Technical College is the first in the state to launch the all-new SCBIO Life Sciences Pharmaceutical Manufacturing certificate program. The program will help to build a workforce pipeline for positions in what is now the Palmetto State’s fastest-growing industry.

    To the gratification of many but the surprise of none of the organizers, the class was completely filled within 48 hours of registration opening. The inaugural class graduated May 6, 2022.

    Developed in conjunction with SCBIO, the statewide organization dedicated exclusively to advancing and growing life sciences in South Carolina, the 48-hour curriculum was developed in partnership with numerous industry partners. The certificate program is the first of several planned for rollout over the next 12 months. A similar program is nearing launch at Greenville Technical College.

    Highlights of the program include an overview of the pharmaceutical industry; introduction to quality assurance principles; a regulatory overview; documentation practices and measurement skills; and 12 hours towards Essential Skills for the Workplace certificate.

    “Midlands Technical College is proud to be the educational partner for this pilot program that supports the life science industry, a high growth industry in the Palmetto State. We are always interested in providing our community with the education needed to be successful in the workforce,” said  Ryan Hemby, Business Solutions Director for Midlands Technical College.

    Tuition for the program is covered by industry partners. People interested in registering for upcoming classes should visit https://midlandstech.formstack.com/forms/scbio.

    The pilot program, the first of its kind in South Carolina offered by the Technical College System, reflects the growing demand for skilled workers to continue fueling the rapidly expanding life sciences industry, which has a presence in 42 of the state’s 46 counties, boasts a more-than-$25 billion annual economic impact, and features average wages nearly 80% higher than South Carolina’s average wage.

    “Life sciences is a major driver of South Carolina’s economy today, and this new certificate program is a first step in addressing the talent needs of the industry’s surging growth, reach and rapidly rising economic significance,” noted SCBIO Executive Vice President and COO Erin Ford, a key organizer of the statewide initiative. “We’re laser focused on doing all that we can to train, retrain and encourage South Carolinians to pursue and prepare for careers in life sciences, an industry that improves quality of life and economic standing for South Carolina citizens.”

    While SCBIO is focused on developing programs for the Technical College System, it also has initiatives underway with state colleges and universities, connecting students interested in careers in life sciences with industry partners seeking talent, and with K-12 students where life science career paths and awareness of STEM opportunities are shared with schools and students statewide.

    Recently, Governor Henry McMaster issued a proclamation recognizing South Carolina Life Sciences Week in the Palmetto State in testament to its growth of more than 42% since 2017. Since 2017, South Carolina also is growing its life sciences industry employment at a faster rate than any other Southeastern state, Ms. Ford noted.

    Even the growth of the state’s firm count is extraordinary, having grown from 402 firms counted in the Palmetto State in the 2016 study to 1,033 firms today in the rapidly expanding ecosystem. And life sciences impact the entire state, with a current presence of industry organizations in 42 of 46 state counties.

    For additional information on SCBIO, visit www.SCBIO.org.  For additional information on MTC, visit www.MidlandsTech.edu.

  • sam patrick posted an article
    Enzyme and protein biotech leader creates, manufactures, distributes next gen products see more

    South Carolina’s Integrated Micro-Chromatography Systems, Inc. (IMCS), a leader in recombinant enzymes and micro-chromatography technologies, was awarded $1.8 million for Phase II of its Fast-Track Small Business Innovation Research (SBIR) grant from the National Institutes of Health/ National Institute of General Medical Sciences (NIH/NIGMS).

    Combined with earlier SBIR funding, the grant will provide scientists access to affordable gangliosides that aid in developing therapeutics and diagnostics for neurological diseases including Huntington's Disease, Parkinson's Disease, and Alzheimer's Disease.

    The NIH/NIGMS previously awarded IMCS a 4-year, $2.56 million Fast-Track Small Business Technology Transfer (STTR) grant to expand the glycan toolkit and build an extensive array of sialoglycans that advance glycobiology-related research. The combined Fast-Track grants for the projects now exceeds $5.25 million. These projects will provide the scientific community access to affordable, easy-to-use reaction kits to facilitate synthesis of various glycans to advance research into potential diagnostics and therapeutics for neurodegenerative diseases.

    The SBIR project is headed by L. Andrew Lee, Ph.D., co-founder and Chief Scientific Officer of IMCS, along with Xi Chen, Ph.D., Professor of Chemistry at the University of California, Davis. The STTR project is in collaboration with Hai Yu, Ph.D., Project Scientist at the UC-Davis.

    Glycobiology, the study of the biological impact of sugars, has gained momentum in recent years. The surfaces of viruses, bacteria, and cells of our bodies are decorated with unique sugars or glycans. Some viruses and bacteria can exploit glycans to wreak havoc on our bodies, while a lack of glycans can result in disease progression. Studies suggest that modifications to certain glycans in molecules related to the brain are implicated in the onset and progression of neurodegenerative diseases.

    To date, the high cost of reagents and materials needed for glycobiology research have contributed to few tools to study glycans. Glycan-modified cell membranes (glycolipids) and gangliosides (a component of brain matter critical to research) must be harvested from pigs, sheep, and cows as there is currently no cost-effective manufacturing process. The biosynthetic manufacturing technology used for these projects will result in animal-free gangliosides.

    Matthew Macauley, Ph.D., Assistant Professor of Chemistry at the University of Alberta, is eager to access significant quantities of gangliosides. "Some experiments with glycolipids are cost-prohibitive, but scalable and facile access to glycolipids would make such experiments financially feasible,” he noted.

    While not involved in the grant, Dr. Macauley’s lab studies glycan-binding proteins called Siglecs and their impact on disease states such as Alzheimer’s. Noting that commercially available glycolipids do not capture the diversity needed in research, he notes that reaction kits funded by the grant could be “a tremendous help for a lab that doesn't have expertise with glycan synthesis and doesn’t want to invest in getting all these enzymes expressed.”

    Research reported in this press release was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Numbers R44GM139441 and R42GM143998. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

    About IMCS

    Integrated Micro-Chromatography Systems, Inc is a privately held biotechnology company that strives to address the growing needs of clinical and research laboratories through innovative technologies and custom solutions designed to increase testing efficiency. IMCS creates, manufactures, and distributes next-generation biotechnology products to clinical and forensic toxicology, academic research facilities, US Government agencies, and health science companies around the world.

  • sam patrick posted an article
    Heartbeat Technologies, Integrated Micro-Chromatography Systems, and Victory Exofibres were accepted see more

    Heartbeat Technologies, Integrated Micro-Chromatography Systems, and Victory Exofibres were accepted as South Carolina Research Authority (SCRA) Member Companies. All SCRA Member Companies receive coaching, access to experts in SCRA’s Resource Partner Network, eligibility to apply for grant funding, and the potential to be considered for an investment from SCRA’s investment affiliate, SC Launch Inc.

    Heartbeat Technologies LLC has been accepted as an SCRA Member Company. The Charleston-based startup is dedicated to improving cardiac arrest outcomes and developed a device called ‘The SAVER,’ to better perfuse the heart and brain during emergency events.

    Integrated Micro-Chromatography Systems Inc has been accepted as an SCRA Member Company. The Irmo-based startup creates, manufactures, and distributes next-generation biotechnology products to clinical and forensic toxicology organizations, academic research facilities, federal government agencies, and health science companies.

    Victory Exofibres LLC  has been accepted as an SCRA Member Company. The Greenville-based startup company produces super-efficient viral particle isolation kits that enable more efficient medical diagnostic testing.

    SCRA welcomes these new Member Companies.

    Grant funding is made possible, in part, by the Industry Partnership Fund (IPF) contributions that fuel the state’s innovation economy. Contributors to the IPF receive a dollar-for-dollar state tax credit, making it an easy and effective way to help one of the fastest growing segments of the South Carolina economy. Grant funding for Member Companies creates a direct, positive economic effect and job creation.

    ###

    About SCRA
    https://scra.org/
    Chartered in 1983 by the State of South Carolina as a public, nonprofit corporation, South Carolina Research Authority (SCRA) fuels South Carolina’s innovation economy through the impact of its four programs. SC Academic Innovations provides funding and support to advance translational research and accelerate the growth of university-based startups. SC Facilities offers high-quality laboratory and administrative workspaces for technology-based startups and academic institutions. SC Industry Solutions facilitates and funds partnerships between and among startups, industry, and academia. SC Launch mentors and funds technology-based startups that may also receive investments from SCRA’s investment affiliate, SC Launch, Inc.